Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H11N3O3S |
Molecular Weight | 253.278 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
InChI
InChIKey=JLKIGFTWXXRPMT-UHFFFAOYSA-N
InChI=1S/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)
Molecular Formula | C10H11N3O3S |
Molecular Weight | 253.278 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:35:10 UTC 2023
by
admin
on
Fri Dec 15 15:35:10 UTC 2023
|
Record UNII |
JE42381TNV
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ESSENTIAL MEDICINES LIST |
6.5.4 (SUL/TRI)
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.2.2 (SUL/TRI)
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
||
|
NDF-RT |
N0000008048
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
||
|
WHO-ATC |
J01EE01
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
||
|
WHO-VATC |
QJ01EQ11
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
||
|
WHO-VATC |
QJ01EW11
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
||
|
NCI_THESAURUS |
C29739
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
||
|
NDF-RT |
N0000008048
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
||
|
LIVERTOX |
NBK547937
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
||
|
NDF-RT |
N0000175504
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
||
|
WHO-ATC |
J04AM08
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
||
|
WHO-ATC |
J01EC01
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
||
|
NDF-RT |
N0000008048
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Sulfamethoxazole
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
9332
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
DTXSID8026064
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
JE42381TNV
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
SULFAMETHOXAZOLE
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
2514
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
SUB10711MIG
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
C47737
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
10180
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | RxNorm | ||
|
SULFAMETHOXAZOLE
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | Description: A white or yellowish white, crystalline powder; odourless. Solubility: Very slightly soluble in water; soluble in 50 parts of ethanol (~750 g/l) TS and in 3 parts of acetone R. Category: Antibacterial. Storage: Sulfamethoxazole should be kept in a well-closed container, protected from light. Definition: Sulfamethoxazole contains not less than 99.0% and not more than 101.0% of C10H11N3O3S, calculated with reference to the dried substance. | ||
|
N0000185504
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | Cytochrome P450 2C9 Inhibitors [MoA] | ||
|
211-963-3
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
D013420
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
3186
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
CHEMBL443
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
147832
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
5329
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
1631001
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
1386
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
100000092618
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
JE42381TNV
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
DB01015
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
723-46-6
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
Trimethoprim-Sulfamethoxazole
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | |||
|
m10320
Created by
admin on Fri Dec 15 15:35:10 UTC 2023 , Edited by admin on Fri Dec 15 15:35:10 UTC 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
BINDER->LIGAND |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE REACTIVE TYPE->PARENT |
|
||
|
METABOLITE REACTIVE TYPE->PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||